Champolion's Alternative Geron Corporation [NASDAQ: GERN]

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Champolion's Alternative Geron Corporation [NASDAQ: GERN]

An SI Board Since May 1999

Posts	SubjectMarks	Bans
12	1	0

Emcee: Champolion	Type: Unmoderated

Introduction Compact

Geron Corporation

230 Constitution Dr.
Menlo Park, CA 94025

Phone: 650-473-7700
Fax: 650-473-7701

geron.com

If Geron could turn back time, it would make a lot of money. The
company (which takes its name from the Greek word for old man)
conducts research on the aging process, focusing on telomeres,
structures that act as a molecular "clock" for cellular aging, and
telomerase, an enzyme that seems to prolong the cellular lifespan. By
creating a telomerase inhibitor, Geron hopes to allow the telomeres
of a cancerous cell to continue aging and eventually die. Its
research has applications to skin aging, osteoporosis, and
Alzheimer's disease. Geron has research collaborations with the
research groups at Johns Hopkins and University of Wisconsin that
discovered a method for culturing human stem cells.

Copyright © 1999, Hoover's, Inc.
Austin, Texas

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
12	Hi: I've been fascinated with this company since reading Reversing Human A	Ann Bradley	-	5/5/1999
11	Thanks Mike, for the post... I previously posted a number of link to some fund	Champolion	-	5/4/1999
10	Geron Announces Issuance of Patent for Human Telomerase Protein and Ten Other P	Champolion	-	5/4/1999
9	Geron is Pleased With NIH Decision Regarding Funding of Research Using Derived	Champolion	-	5/4/1999
8	Geron Announces First In Vivo Data Indicating Telomerase Expression in Normal H	Champolion	-	5/4/1999
7	Geron Announces $15 Million in Financing -> elibrary.com@library_i&dtyp	Champolion	-	5/4/1999
6	Geron Announces Issuance of Patent for Primate Embryonic Stem Cells and Four Ot	Champolion	-	5/4/1999
5	TESTIMONY OF THOMAS OKARMA, Ph.D., M.D. VICE PRESIDENT OF RESEARCH AND DEVELOPM	Champolion	-	5/4/1999
4	Champolion... > > > > > > > > > > >	mike head	-	5/4/1999
3	U.S. SENATOR ARLEN SPECTER (R-PA) CHAIRMAN U.S. SENATOR ARLEN SPECTER (R-PA) HO	Champolion	-	5/4/1999
2	(BW)(GERON-2)(GERN) PNAS Reports Derivation of Human Pluripotent Stem Cells Fro	Champolion	-	5/4/1999
1	Hi, I will start this alternative GERN thread with some background information	Champolion	-	5/4/1999

Go to reply# or date (mm/dd/yy):